沙索预计全年收益回升

Core Viewpoint - The company expects a significant recovery in annual earnings driven by rising chemical sales prices, reduced asset impairments, and ongoing cost control measures [1] Financial Performance - The company projects earnings per share to range between 7 to 12 Rand, benefiting from a year-on-year increase in average chemical prices and strict cost management [1] - For the fiscal year 2024 to 2025, the company's pre-tax impairment losses are expected to drop significantly to 20.7 billion Rand, compared to 74.9 billion Rand in the same period last year [1] - This anticipated earnings turnaround contrasts sharply with a loss of 69.94 Rand per share in the fiscal year 2023 to 2024 [1] - The adjusted EBITDA is projected to decline by 10% to 17%, falling within the range of 50 billion to 54 billion Rand [1]